CryoPort Inc (CYRX)

[laser777]

First, the product has 4 billion in sales not 3.
I can tell you never invest in biotech, esprcially immunotherapy,
because there are always delays. Especially immunotherapy, because it is so new.

If you will not take the time to listen to the call or even read it, I don't know what to tell you! You just start a rant and go off, because the stock is not $50.00 yet. I have been in this stock for over 6 years, I know not as long as you, but I will be patient a while longer.

Clinical trials as they relate to us through progression generally and for a revenue ramp moving to the clinical stages of development to commercialization. For example, revenue to Cryoport for Phase I trials might typically range from $15,000 to $75,000 annually. For Phase II $50,000 to $150,000 and for Phase III $200,000 to $1 million, and for commercialization $3 million to $20 million-plus. So you can readily see why I say we are just at the tip of the iceberg[/b

Do you see it says ANNUALLY.
It takes big pharma a very long time to seal a deal, especially one with a 30 million marketcap.